Adaptive Biotechnologies Corp. (ADPT)
15.20
-0.85
(-5.30%)
USD |
NASDAQ |
Feb 20, 16:00
15.20
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Market Cap : 2.337B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 151.52B |
| Gilead Sciences, Inc. | 187.84B |
| Regeneron Pharmaceuticals, Inc. | 82.43B |
| Recursion Pharmaceuticals, Inc. | 1.780B |
| Arcellx, Inc. | 3.707B |
Market Cap Related Metrics
| PS Ratio | 8.473 |
| Price to Book Value | 10.68 |
| Price | 15.20 |
| Earnings Yield | -2.62% |